Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Abstract Background To assess the performance of plasma neurofilament light (NfL) and phosphorylated tau 181 (p-tau181) to inform about cerebral Alzheimer’s disease (AD) pathology and predict clinical progression in a memory clinic setting. Methods Plasma NfL and p-tau181, along with established cer...

Description complète

Détails bibliographiques

Auteurs principaux:	Christopher Clark, Piotr Lewczuk, Johannes Kornhuber, Jonas Richiardi, Bénédicte Maréchal, Thomas K. Karikari, Kaj Blennow, Henrik Zetterberg, Julius Popp
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2021-03-01
Collection:	Alzheimer’s Research & Therapy
Sujets:	Biomarkers Plasma Alzheimer’s Neurofilament light p-tau181
Accès en ligne:	https://doi.org/10.1186/s13195-021-00805-8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!